ArticleEJNMMI physics2026
Assessing the suitability of automated registration and segmentation for dosimetry calculations in SIRT treatment planning.
Article in EJNMMI physics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundSelective internal radiation therapy (SIRT) increasingly relies on accurate magnetic resonance imaging (MRI) to computed tomography (CT) registration and accurate liver and tumour segmentation, for effective pre-treatment planning. This study evaluates the impact of automatic registration and segmentation techniques on dosimetry calculations for SIRT treatment planning. It compares semi-automatic and automatic registration, as well as manual and automatic deep learning-based segmentation.
methodsPre-treatment data from 90 patients with hepatocellular carcinoma were analysed. The dataset consisted of contrast-enhanced T1-weighted MRI scans with manually delineated liver and tumour volumes of interest (VOIs), as well as single-photon emission computed tomography (SPECT)/CT scans with manually or semi-automatically delineated liver VOI. The clinical routine pipeline, which involves semi-automatic registration and manual/semi-automatic segmentation, was used as the baseline pipeline and compared to experimental pipelines that use intensity-based deformable automatic registration or deep learning-based automatic segmentation. Dosimetric accuracy was assessed via metrics such as the mean absorbed dose, the minimum dose received by 70% of the volume (D70), and inverted cumulative dose-volume histograms.
resultsSemi-automatic and automatic MRI to CT liver registration achieved comparable Dice scores of 92%. However, tumour registration varied significantly between registration methods yielding average Dice scores of 79%. Multimodal tumour segmentation approaches outperformed monomodal ones, achieving average Dice scores of 66.6 versus 62.5%. Using the baseline pipeline, the average tumour absorbed dose per patient was 115.6 Gy. Using the fully automatic approach, tumour absorbed doses differed from baseline values by an average of 6.6 Gy. Differences ranged from 0.3 Gy in the best case to 202.8 Gy when the automatic tumour segmentation markedly deviated from the manual delineation. Finally, it was found that a Dice score of at least 80% was required to avoid statistically significant differences in absorbed dose estimates between the clinical and automatic approaches.
conclusionSemi-automatic and automatic registration show equivalent performance, allowing for complete automation. Automatic segmentation demonstrates promising results, with approximately 40% of patients achieving tumour Dice scores above the 80% threshold. 30% of cases show intermediate performance (60-80% tumour Dice scores), while the remaining 30% are still challenging. Further refinement of segmentation methods is required to enhance dosimetric accuracy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.